Anti-SPON1/ VSGP/F-spondin/ f-spondin functional antibody

Anti-SPON1/ VSGP/F-spondin/ f-spondin functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SPON1/SPON1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1317-Ab-1/ GM-Tg-hg-SE1317-Ab-2Anti-Human SPON1 monoclonal antibodyHuman
GM-Tg-rg-SE1317-Ab-1/ GM-Tg-rg-SE1317-Ab-2Anti-Rat SPON1 monoclonal antibodyRat
GM-Tg-mg-SE1317-Ab-1/ GM-Tg-mg-SE1317-Ab-2Anti-Mouse SPON1 monoclonal antibodyMouse
GM-Tg-cynog-SE1317-Ab-1/ GM-Tg-cynog-SE1317-Ab-2Anti-Cynomolgus/ Rhesus macaque SPON1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1317-Ab-1/ GM-Tg-felg-SE1317-Ab-2Anti-Feline SPON1 monoclonal antibodyFeline
GM-Tg-cang-SE1317-Ab-1/ GM-Tg-cang-SE1317-Ab-2Anti-Canine SPON1 monoclonal antibodyCanine
GM-Tg-bovg-SE1317-Ab-1/ GM-Tg-bovg-SE1317-Ab-2Anti-Bovine SPON1 monoclonal antibodyBovine
GM-Tg-equg-SE1317-Ab-1/ GM-Tg-equg-SE1317-Ab-2Anti-Equine SPON1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1317-Ab-1/ GM-Tg-hg-SE1317-Ab-2; GM-Tg-rg-SE1317-Ab-1/ GM-Tg-rg-SE1317-Ab-2;
GM-Tg-mg-SE1317-Ab-1/ GM-Tg-mg-SE1317-Ab-2; GM-Tg-cynog-SE1317-Ab-1/ GM-Tg-cynog-SE1317-Ab-2;
GM-Tg-felg-SE1317-Ab-1/ GM-Tg-felg-SE1317-Ab-2; GM-Tg-cang-SE1317-Ab-1/ GM-Tg-cang-SE1317-Ab-2;
GM-Tg-bovg-SE1317-Ab-1/ GM-Tg-bovg-SE1317-Ab-2; GM-Tg-equg-SE1317-Ab-1/ GM-Tg-equg-SE1317-Ab-2
Products NameAnti-SPON1 monoclonal antibody
Formatmab
Target NameSPON1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SPON1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1317-Ag-1Recombinant multi-species SPON1/ VSGP/F-spondin/ f-spondin protein
    ORF Viral VectorvGMLP001799human SPON1 Lentivirus particle
    ORF Viral VectorpGMLP001799human SPON1 Lentivirus plasmid


    Target information

    Target IDGM-SE1317
    Target NameSPON1
    Gene ID10418,233744,64456,699833,476864,101094373,282866,100056137
    Gene Symbol and SynonymsD330035F22Rik,f-spondin,FSP,SPON1,Sponf,VSGP/F-spondin
    Uniprot AccessionQ9HCB6,P35446,Q9GLX9
    Uniprot Entry NameSPON1_HUMAN,SPON1_RAT,SPON1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseOvary Cancer
    Gene EnsemblENSG00000262655
    Target ClassificationN/A

    The target: SPON1, gene name: SPON1, also named as VSGP/F-spondin, f-spondin. Predicted to be an extracellular matrix structural constituent. Predicted to be involved in cell adhesion. Predicted to act upstream of or within positive regulation of protein binding activity; positive regulation of protein processing; and regulation of amyloid precursor protein catabolic process. Located in extracellular space. Colocalizes with collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.